Published Date: 13 Mar 2023
Among other things, international students seek connections and advice on how to better compete by supporting community groups.
Read Full NewsA retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.
For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.
Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.
Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.
1.
Best foot forward—chemo care should include podiatry, say researchers
2.
Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?
3.
High weight and obesity are associated with poor outcomes in leukemia treatment.
4.
Researchers discover that children who survive cancer have socioeconomic challenges.
5.
Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.
1.
The Journey Beyond Treatment: Empowering Cancer Survivorship with Technology and Artificial Intelligence
2.
Contemporary Approaches in Hematology for Specialists
3.
The Algorithmic Oncologist: A Comparative Clinical Review of AI in Predictive Cancer Planning
4.
Exploring the Potential of Cytologic Atypia in Cancer Diagnosis
5.
Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
2.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
3.
Oropharyngeal Cancer in Relation to HPV Status
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation